Lincoln [LINCOLN] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Lincoln
NSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lincoln wins in 17 metrics, Sequent Scientific wins in 2 metrics, with 0 ties. Lincoln appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lincoln | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.34 | 166.33 | Lincoln |
| Price-to-Book Ratio | 1.59 | 6.61 | Lincoln |
| Debt-to-Equity Ratio | 0.00 | 62.47 | Lincoln |
| PEG Ratio | 0.73 | 1.40 | Lincoln |
| EV/EBITDA | 8.46 | 30.63 | Lincoln |
| Profit Margin (TTM) | 13.71% | 1.85% | Lincoln |
| Operating Margin (TTM) | 13.19% | 7.56% | Lincoln |
| EBITDA Margin (TTM) | 13.19% | 7.56% | Lincoln |
| Return on Equity | 12.26% | 2.84% | Lincoln |
| Return on Assets (TTM) | 10.33% | 1.37% | Lincoln |
| Free Cash Flow (TTM) | $737.71M | $442.73M | Lincoln |
| Dividend Yield | 0.32% | N/A | N/A |
| 1-Year Return | -19.68% | -10.14% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 1.69 | 3.00 | Lincoln |
| Enterprise Value | $8.70B | $50.87B | Sequent Scientific |
| EV/Revenue Ratio | 1.38 | 3.17 | Lincoln |
| Gross Profit Margin (TTM) | 54.96% | 46.86% | Lincoln |
| Revenue per Share (TTM) | $315 | $64 | Lincoln |
| Earnings per Share (Diluted) | $43.14 | $1.12 | Lincoln |
| Beta (Stock Volatility) | 0.19 | 0.91 | Lincoln |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Lincoln vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lincoln | 0.11% | -0.88% | -4.12% | -4.76% | -7.24% | -37.86% |
| Sequent Scientific | 1.15% | -8.42% | 9.29% | -3.35% | 37.17% | 0.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lincoln | -19.68% | 82.29% | 118.12% | 147.47% | 147.47% | 147.47% |
| Sequent Scientific | -10.14% | 69.59% | 19.72% | 26.36% | 26.36% | 26.36% |
News Based Sentiment: Lincoln vs Sequent Scientific
Lincoln
News based Sentiment: MIXED
September presented a mixed bag for Lincoln Pharmaceuticals, with a concerning revenue decline in Q3 offset by a strong Q1 FY26 performance. The conflicting signals from analysts and declining investor interest create a complex investment picture, making this a significant month for understanding the company's trajectory.
Sequent Scientific
News based Sentiment: POSITIVE
Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.
Performance & Financial Health Analysis: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹10.68B | ₹48.13B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 17,397 | 1,494,055 |
| 90 Day Avg. Volume | 22,422 | 754,164 |
| Last Close | ₹532.55 | ₹186.29 |
| 52 Week Range | ₹499.00 - ₹979.50 | ₹117.35 - ₹240.70 |
| % from 52W High | -45.63% | -22.60% |
| All-Time High | ₹979.50 (Dec 09, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -45.63% | -44.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.13% |
| Quarterly Earnings Growth | 0.17% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.02% |
| Operating Margin (TTM) | 0.13% | 0.08% |
| Return on Equity (TTM) | 0.12% | 0.03% |
| Debt to Equity (MRQ) | 0.00 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹335.40 | ₹28.19 |
| Cash per Share (MRQ) | ₹97.95 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹967.87M | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹823.46M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.32% | N/A |
| Last 12-Month Dividend | ₹1.80 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.34 | 166.33 |
| Forward P/E | N/A | 36.89 |
| PEG Ratio | 0.73 | 1.40 |
| Price to Sales (TTM) | 1.69 | 3.00 |
| Price to Book (MRQ) | 1.59 | 6.61 |
| Market Capitalization | ||
| Market Capitalization | ₹10.68B | ₹48.13B |
| Enterprise Value | ₹8.70B | ₹50.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.38 | 3.17 |
| Enterprise to EBITDA | 8.46 | 30.63 |
| Risk & Other Metrics | ||
| Beta | 0.19 | 0.91 |
| Book Value per Share (MRQ) | ₹335.40 | ₹28.19 |
Financial Statements Comparison: Lincoln vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹1.54B | ₹4.41B |
| Cost of Goods Sold | ₹693.84M | ₹2.35B |
| Gross Profit | ₹846.82M | ₹2.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹203.27M | ₹333.50M |
| EBITDA | ₹390.76M | ₹505.30M |
| Pre-Tax Income | ₹353.89M | ₹255.20M |
| Income Tax | ₹77.14M | ₹79.50M |
| Net Income (Profit) | ₹276.75M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹134.14M | ₹626.60M |
| Total Current Assets | ₹5.00B | ₹8.74B |
| Total Current Liabilities | ₹1.06B | ₹5.05B |
| Long-Term Debt | N/A | ₹3.00B |
| Total Shareholders Equity | ₹6.72B | ₹7.70B |
| Retained Earnings | ₹5.86B | ₹1.25B |
| Property, Plant & Equipment | ₹220.84M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 17,397 | 1,494,055 |
| Average Daily Volume (90 Day) | 22,422 | 754,164 |
| Shares Outstanding | 20.03M | 249.89M |
| Float Shares | 8.79M | 118.88M |
| % Held by Insiders | 0.55% | 0.52% |
| % Held by Institutions | 0.01% | 0.13% |
Dividend Analysis & Yield Comparison: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹1.80 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.32% | N/A |
| 3-Year Avg Annual Dividend | ₹1.70 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.29% | N/A |
| 3-Year Total Dividends | ₹5.10 | ₹0.00 |
| Ex-Dividend Date | Sep 12, 2025 | N/A |